CSGs, Balancing

CSG's Balancing Act: Record Orders and a €1.2 Billion Cash Bind

Published on 08/10/2026 at 11:52 | Redaktion boerse-global.de

CSG's H1 revenue rose 17%, but a €1.2B working capital surge lifted net debt to 2.9B, triggering profit-taking despite reaffirmed guidance.

CSG Shares Dip on Working Capital Build, But Defence Growth and Backlog Remain Strong
CSG's Balancing Act: Record Orders and a €1.2 Billion Cash Bind Illustration mit AI erstellt übermittelt durch boerse-global.de

The defence industry's current bull run has a way of punishing companies that deliver exactly what investors asked for — just not all at once. That was the lesson for Czechoslovak Group (CSG) this week, as the Prague-based industrial conglomerate saw its shares swing sharply in both directions following its half-year report, with the market ultimately fixating on a balance-sheet detail rather than the headline growth figures.

After climbing 6.88 percent on Thursday's earnings release to close at €18.10, the stock gave back those gains on Friday as investors digested the full picture. By Monday, the shares were changing hands at €17.66, down another 2.47 percent. Yet even with the two-day pullback, the equity remains up roughly 29–32 percent over the past month — a reminder that the recent turbulence is profit-taking, not a reversal of the group's trajectory.

The Numbers That Impressed — and the One That Didn't

On the surface, CSG's first-half performance offered little to criticise. Revenue climbed 17.2 percent year-on-year to €3.3 billion, marginally ahead of consensus expectations. Operating EBIT rose 13 percent to €784 million, translating to a margin of 24.1 percent — comfortably within management's guided range. The group reaffirmed its full-year 2026 outlook of €7.4–7.6 billion in revenue and an operating EBIT margin of 24–25 percent.

The defence segment, unsurprisingly, did the heavy lifting. Defence Systems grew 27 percent, while the Land Systems division doubled its revenue to €445 million. That unit now accounts for 46 percent of the group's €17 billion order backlog, a figure that underscores how quickly CSG has pivoted toward armoured vehicles and land-based equipment.

Should investors sell immediately? Or is it worth buying CSG?

What unsettled the market was the capital side of the ledger. Working capital ballooned by €1.2 billion, a build-up driven largely by strategic stockpiling of components for medium- and large-calibre ammunition. The result: net debt climbed to €2.914 billion, pushing the net-debt-to-EBITDA ratio to 1.6 — well above the sub-1.3 level management had targeted for year-end.

Management insists this is a timing issue, not a structural one. The inventory is expected to unwind in the second half, particularly in the fourth quarter, and the group has reaffirmed its guidance for net working capital to stay below 20 percent of revenue for the full year.

Ammunition at the Core

The component stockpiling is directly tied to CSG's most ambitious production targets. The group currently produces around 550,000 rounds of large-calibre ammunition annually; by the end of 2026, it aims to lift that to roughly 850,000, and to 1.1 million by the end of 2027. A related goal: 60 percent of long-range ammunition manufactured in-house by the end of this year, with full vertical integration targeted for end-2027.

Demand for 155mm shells with extended range remains robust, particularly from Ukraine, though the customer mix is shifting. The Ukraine share of CSG's revenue has fallen from 27 percent to 17 percent as NATO member states step up their own stockpile replenishment and push for domestic production capacity — a segment where European suppliers remain scarce.

Building the Industrial Footprint

Beyond the production lines, CSG has been quietly expanding its geographic and technological reach. In Germany, subsidiary CSG Energetic Materials Germany GmbH completed the acquisition of a 57-hectare industrial site in Gnaschwitz near Bautzen, Saxony, from MAXAM. The first expansion phase involves investments exceeding €100 million to establish production for nitroglycerin and nitroglycerin-based products, as well as ammunition and ammunition components.

Across the Atlantic, the group has established CSG Land Systems North America, opened a Washington D.C. office, and broken ground on the Future Artillery Complex in Iowa. A new joint venture, Firecrest Aerospace, is set to broaden the group's drone and engine capabilities.

CFO Zdenek Jurak told Reuters that the group is now looking beyond ammunition and ground equipment toward "high-tech topics" such as turbine jet engines, with supply chains secured and no expected impact from the Middle East conflict.

CSG at a turning point? This analysis reveals what investors need to know now.

Canada has also drawn CSG's attention: the group took a strategic minority stake in North Vector Dynamics, a developer of air defence technologies, precision-guided munitions, counter-drone systems and next-generation hypersonics. The investment amount remains undisclosed, though the Canadian firm's valuation now exceeds $90 million.

A New Hand at the Top

Adding to the strategic momentum, Ben Hudson joined the Board of Directors of Czechoslovak Group a.s. on August 1 as member and vice-chairman. Hudson, who has spent over three decades in the global defence industry, had already been serving as CEO of CSG Land Systems and group CTO since June 2026. His résumé includes stints as CEO of Hanwha Europe, UK and Australia, Group Chief Technology Officer at BAE Systems, and Global Head and CEO of the Vehicle Systems Division at Rheinmetall.

The Investor Takeaway

The market's mixed reaction to CSG's results reflects a genuine tension. On one hand, the order book is thick, the growth story is intact, and the strategic positioning — from US expansion to high-tech diversification — looks increasingly coherent. On the other, the €1.2 billion working capital build and the leverage creep are real concerns that won't fully resolve until the inventory converts to cash.

Management has signalled that the fourth quarter should bring relief, and the reaffirmed guidance offers a benchmark against which progress can be measured. For now, the shares' recent pullback looks less like a verdict on the company's strategy and more like a pause — a moment for the market to see whether the balance sheet can catch up with the ambition.

Ad

CSG Stock: New Analysis - 10 August

Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated CSG analysis...

Disclaimer...

en | NL0015073TS8 | CSGS | boerse | 69932342 |